Citizen Petitions Cannot Be Used To Block Generics - FDA Proposed Rule

Innovator pharmaceutical companies will not be able to block approval of generic drugs by using the citizen petition mechanism, according to FDA's Nov. 30 proposed rule to revise the petition process.